Moderne Ventures announces the six companies selected to join its exclusive Moderne Passport industry immersion program
CHICAGO, April 10, 2025 /PRNewswire/ -- Moderne Ventures announced its first 2025 Passport Class. Moderne Ventures is a strategic venture capital and growth equity firm investing in disruptive technologies that can apply to both Moderne's core industries (real estate, insurance, finance, and sustainability) and expand beyond them to capture larger venture returns. The Moderne Passport Program is an intensive six-month industry immersion program providing its participants with education, exposure, insight, and relationships to drive customer growth.
"At Moderne, we take a generalist approach to vertical investing, looking outside of our core industries to find technologies that can be applicable within them," said Constance Freedman, Founder and Managing Partner at Moderne Ventures. "This latest Passport cohort includes breakthrough crypto payments technology, digital transaction management and video games creating transformative opportunities for multi-trillion dollar markets."
The Moderne Passport program hosts companies of all stages – in this cohort, companies range from seed to Series C and have raised over $220M+ in aggregate of funding with collective valuations of $900M+. The companies are:
Audette (audette.io) – (Vancouver, British Columbia): Turning decarbonization from a cost center to a strategic competitive advantage
Closing Theory (closingtheory.com) – (Austin, TX): Closing Theory Studios is unlocking the $200B gaming market with its first mobile game, HouseHunt—a Monopoly-meets-Zillow experience that transforms real home listings into a fun, empire-building challenge
Mesh (meshconnect.com) – (San Francisco, CA): The first global crypto payments network enabling real-time, seamless crypto payments on anything from retail to rent
Trust & Will (trustandwill.com) – (San Diego, CA): Digitizing and democratizing estate planning for families while empowering enterprises to support clients and employees
WarrantyHive (warrantyhive.com) – (American Fork, UT): Manage facility warranties easier, faster and smarter with AI
Work& (workandsolutions.com) – (Houston, TX): Work is more than just getting a job done – Work& provides legally-compliant lactation and wellness solutions to seamlessly integrate work, parenthood, and wellbeing on the job
"We celebrate this class as our 21st Moderne Passport cohort, having guided over 150 startups through our program. Our program unlocks new distribution channels by leveraging our extensive network of industry partners who are excited to work with these innovative startups," notes Carolyn Kwon, Moderne Ventures' Head of Platform.
Moderne Ventures accepts Passport applications on a rolling basis with the next class launching in May.
About Moderne Ventures
Moderne Ventures is a strategic venture capital and growth equity firm with a 17-year track record, generating top tier returns across five funds. Moderne is a generalist investor with vertical expertise with a particular focus on technologies like Enterprise SaaS, AI, Robotics, Deep Tech, Sustainability, and Data and Digital Transaction Management and targets technologies that can apply to both Moderne's core industries and expand beyond them to deliver outsized venture returns.
Moderne's 'secret sauce' is bringing Customers to its Portfolio Companies. Moderne has built an extraordinary network of over 1,500 executives and corporations within multi trillion-dollar industries ripe for innovation and disruption, including real estate, finance, insurance, and sustainability. Through Moderne Passport, an industry immersion program, Moderne programmatically connects its portfolio to its industry network to help generate growth for the portfolio and outsized returns to investors.
Moderne operates both early-stage and late-stage Venture Funds and the Moderne Passport, designed to foster innovation, partnership and growth between industry partners and emerging technology companies. Moderne has invested in ~50 companies with additional equity stakes in ~150 Passport companies across five funds, and has built a stellar track record through investing in companies like DocuSign, ICON, Measurabl, Proof, Caribou, Porch, and Xeal.
CONTACT: Carolyn Kwon, carolyn@moderneventures.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/moderne-ventures-announces-the-six-companies-selected-to-join-its-exclusive-moderne-passport-industry-immersion-program-302425743.html
SOURCE Moderne Ventures
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
Monk Fruit Sweeteners Market to Reach $147.2 Million by 2032, Driven by Health Consciousness and Clean-Label Trends, Says Meticulous Research®
A new report by Meticulous Research® forecasts the global monk fruit sweeteners market to grow at a CAGR of 4.5% from 2025 to 2032 REDDING, Calif., June 30, 2025 /PRNewswire/ -- According to a comprehensive market research report titled "Monk Fruit Sweeteners Market Size, Share, Forecast, & Trends Analysis by Product Type (Monk Fruit Extract), Form (Solid), Category (Organic), Packaging Type, Application (Beverages, Food), Distribution Channel (B2B) - Global Forecast to 2032," the monk fruit sweeteners market is projected to reach $147.2 million by 2032, up from an estimated $107.9 million in 2025, growing at a steady CAGR of 4.5% during the forecast period. Market Segmentation Highlights: By Product Type: Monk fruit extracts dominate market with versatile applications in baked goods, beverages, and dietary supplements Monk fruit juice concentrates gaining adoption for natural beverage formulations Monk fruit infusions expanding in specialty health and wellness product categories Concentrated sweetness enabling manufacturers to use smaller quantities for desired sweetness levels To explore the complete report, visit: By Form: Solid form leads with 68.7% market share due to ease of handling, storage, and superior shelf life Liquid form gaining traction in beverage applications and processing convenience Solid formulations preferred for bakery, confectionery, and dry mix applications Versatility across multiple applications driving solid form market dominance By Category: Conventional segment maintaining larger market share with rising consumer demand for natural alternatives Organic segment projected to register highest CAGR with premium food product demand Certified organic products expanding in food & beverage industry applications Clean-label and sugar-free alternatives driving both conventional and organic segment growth By Application Analysis: Beverages segment accounts for 45.3% market share with health benefits and sugar-free product development Food applications expanding with natural sweetening solutions for dairy, bakery, and confectionery Nutrition & health supplements growing with zero-calorie and low glycemic index benefits Natural health and sports drinks with enhanced nutritional value supporting beverage segment growth Regional Market Leadership: North America dominates with 52.8% market share, driven by health consciousness and diabetes awareness Asia-Pacific expected to grow at highest CAGR of 5.1% with China as world's largest monk fruit producer Europe showing significant growth opportunities with clean-label product demand Latin America emerging as high-potential market with rising interest in natural sweeteners Key Market Drivers: Increasing health consciousness among consumers seeking natural, zero-calorie sugar alternatives Growing demand for organic and natural food & beverage products with clean-label attributes Rising prevalence of diabetes and obesity driving low-calorie sweetener adoption Product innovations including 100-250 times sweetness compared to traditional sugar Consumer preference for ingredients free from artificial additives and GMO components Clean-label trend with 78% of global consumers willing to pay premium for transparent products Emerging Market Opportunities: Increasing demand for monk fruit sweeteners in Europe and Latin America markets Rising consumer interest in natural sweeteners replacing artificial alternatives Growing demand for clean-label products emphasizing transparency and natural ingredients Premium positioning of organic monk fruit sweeteners in health-conscious consumer segments Integration with functional foods providing antioxidant effects and blood sugar regulation For more comprehensive insights, download the FREE report sample: Market Challenges: Stringent government regulations affecting product approval and market entry processes Higher prices compared to artificial sweeteners limiting mass market adoption Limited consumer awareness in emerging markets about monk fruit sweetener benefits Supply chain complexities with China as primary source of monk fruit production Insights from the Meticulous Research® Analyst Team: "The monk fruit sweeteners market represents a significant opportunity in the natural sweetener space, with diabetes cases projected to increase from 537 million to 783 million by 2045, driving demand for zero-calorie alternatives. Our research indicates Asia-Pacific will lead growth at 5.1% CAGR, leveraging China's production capabilities and traditional medicine heritage," said Mr. Uddhav Sable, Research Director at Meticulous Research®. Competitive Landscape: Leading market players include Monk Fruit Corp., Guilin Layn Natural Ingredients Corp., Archer-Daniels-Midland Company, GLG Life Tech Corporation, Apura Ingredients Inc., DSM-Firmenich AG, Hunan Huacheng Biotech Inc., Tate & Lyle PLC, Foodchem International Corporation, Whole Earth Sweetener Co. LLC, Lakanto, and Steviva Brands Inc., focusing on product innovation, organic offerings, and strategic partnerships with food & beverage manufacturers. Request a customized research analysis tailored to your specific requirements: About the Report: The 280-page report provides detailed insights into: Market Size & Forecast Analysis (2025–2032) Product Type Performance Benefits & Application Versatility Form Requirements & Packaging Solutions Regional Growth Opportunities & Consumer Behavior Analysis Competitive Landscape & Strategic Product Development Clean-Label Trends & Premium Product Positioning Immediate Delivery Available | Buy this Research Report: Related Reports: Natural Sweeteners Market Size, Share, Trends Analysis 2032 Fruit and Vegetable Ingredients Market Size, Share & Growth Report 2032 Organic Food Market by Size, Share, Forecasts, & Trends Analysis Functional Beverages Market Size, Share, Trends 2031 Juice Concentrates Market: Trends, & Future Growth Analysis About Meticulous Research®: We are a trusted research partner for leading businesses worldwide, empowering Fortune 500 organizations and emerging enterprises with market intelligence designed to drive revenue transformation and strategic growth since 2010. Our insights reveal future growth opportunities, equipping clients with a competitive edge through a versatile suite of research solutions—including syndicated reports, custom research, and direct analyst engagement. To find out more, visit or follow us on LinkedIn Contact: Mr. Khushal Bombe Meticulous Market Research Pvt. Ltd. 1267 Willis St, Ste 200 Redding, California, 96001, U.S. USA: +1-646-781-8004 Europe: +44-203-868-8738 APAC: +91 744-7780008 Email- sales@ Visit Our Website: Connect with us on LinkedIn- Content Source: Logo - View original content to download multimedia: SOURCE Meticulous Market Research Pvt. Ltd. Sign in to access your portfolio
Forbes
8 hours ago
- Forbes
How To Fix Executive Team Performance And Accountability
Even strong executive teams can struggle with creating shared accountability for enterprise results. getty Want to have a high-performing executive team? It's easy to assume that when you bring together smart, capable executives, performance will naturally follow. But in practice, the real barriers to executive team performance aren't about intelligence, strategy, or even trust. They're about a much deeper level of dynamics—unspoken tensions, competing priorities, and the uncomfortable truth that many senior leadership teams never learn how to hold themselves accountable to each other. Here's what's really going on behind the polished slides and well-run meetings—and what teams need to do differently if they want to drive real enterprise value. Most leadership teams know accountability is important. The problem? We tell teams to hold each other accountable—but we don't teach them how. Accountability requires conflict. It means naming when someone hasn't followed through, when priorities are drifting, or when a leader's actions are out of sync with what the team agreed to. That's hard in any environment—and exponentially harder when you're sitting across from someone who has more power, deeper relationships, or a longer tenure. So we avoid it. We say, 'We'll follow up later," or tell ourselves it's not the right time and assume the team leader will step in. And slowly, accountability erodes—not because people don't care, but because we haven't built the skills to do it well. Just telling teams to 'hold each other accountable' is naive. It's like handing someone a scalpel and telling them to perform surgery. It sounds simple—but without the training, it's not going to end well. The real fix is to help leaders learn how to have productive, high-stakes conversations where conflict, candor, and challenge are part of the process—not the exception. These are not soft skills. They are essential executive capabilities. Practical Steps: Train for it. Teach executive teams how to give and receive direct feedback in high-stakes situations—without it getting personal or political. Teach executive teams how to give and receive direct feedback in high-stakes situations—without it getting personal or political. Practice it. Build conflict into your meetings. Assign someone to challenge ideas or play devil's advocate. Reflect on what made a disagreement productive or not. Build conflict into your meetings. Assign someone to challenge ideas or play devil's advocate. Reflect on what made a disagreement productive or not. Reward it. Don't just celebrate outcomes. Celebrate leaders who name hard truths, raise flags early, or hold a peer accountable in service of the team's goals. The Unspoken Rules Run the Room — And That's a Problem for High-Performing Executive Teams Executive teams love to say they value open dialogue. But behind the scenes, there's often a long list of topics that never make it into the room—especially in front of the CEO. Power dynamics, relationships, and politics all play a role. And truthfully, it makes sense—not every conversation can or should happen in the team setting. That's why we pull each other aside in the hallway or debrief one-on-one after the meeting. It's faster, safer, and often, more efficient. But here's the catch: when the real conversations only happen outside the room, the team never learns how to operate with full transparency inside it. And over time, that reinforces a dynamic where people second-guess what they can say, silence themselves, and make safer bets. We avoid the risk of speaking up in the room—so the room stays safe, but also stagnant. The fix isn't to ban backchannels or pretend they don't exist. It's to balance them—and to gently build a culture where team members start saying to each other, 'I think that's something worth raising with the group.' Practical Steps: Encourage transparency, without demanding perfection. It's not about saying everything out loud—it's about recognizing when the team deserves to hear it, more often. It's not about saying everything out loud—it's about recognizing when the team deserves to hear it, more often. Model the shift. As a leader, bring something into the room that you used to handle privately. Show that it's useful to do so. As a leader, bring something into the room that you used to handle privately. Show that it's useful to do so. Use team norms intentionally. Include agreements like, 'If we're having multiple side conversations about a topic, that's a sign it belongs in the room.' If you want real performance, don't just focus on what's being said—start noticing what's being saved for later. Yes, It Can Feel Like Middle School Sometimes On the surface, executive teams operate like composed, high-functioning professionals. But dig deeper and you'll often find something far more familiar: cliques, inside jokes, and informal in-groups that leave others on the outside. Newer executives and external executive hires, especially, can struggle to break in. Long-standing relationships dominate conversations. Some leaders have shared history, inside language, or direct access to the CEO that others don't. It can feel like there's an A-team—and then everyone else. But here's where it gets more complicated: this dynamic is real—but it's also a trap. Feeling excluded can easily lead to the mindset of, 'I'm being excluded,' or, 'This team is the problem, not me.' And that thinking, while understandable, often leads to behaviors—pulling back, judging others, staying quiet, thinking, 'why bother?'—that unintentionally deepen the divide. The more we feel like we don't belong, the more we risk behaving in ways that reinforce our separateness. It becomes a self-fulfilling prophecy. That's why fixing this dynamic takes the willingness to point out if this happening, and the courage to look in the mirror and ask how we're personally showing up. Practical Steps: Treat onboarding to the team like onboarding to the company. Clarify norms, decision-making patterns, and implicit expectations. Assign mentors, sponsors, and coaches to help new members integrate faster. Clarify norms, decision-making patterns, and implicit expectations. Assign mentors, sponsors, and coaches to help new members integrate faster. Leaders feeling like outsiders: Check your narrative. Stay engaged, ask for support. Don't let the dynamic define your value or contribution. Check your narrative. Stay engaged, ask for support. Don't let the dynamic define your value or contribution. For the team as a whole: Normalize talking about inclusion—not just at the org level, but within the team itself. Who speaks most? Who rarely gets the floor? What patterns are we not seeing? Team belonging doesn't just happen. It's created—by the team and by every individual on it. Too Much Going On Limits Executive Team Performance Today's executive teams are pulled in more directions than ever—global priorities, cross-functional initiatives, urgent issues, never-ending decks. As a result, conversations stay surface-level. Meetings devolve into report-outs. Strategic discussions get cut short. We run out of time before we get to the real work. This isn't a discipline problem—it's a design and structure problem. Fix it: Redesign meetings around value. Limit updates to pre-reads. Dedicate time for strategic conversation—and protect it. Ask: What's the most important thing only this team can solve together this week? Then focus there. Final Thought: Build A High-Performing Team Before You Need It Most executive teams are under unbelievable pressure, so it's easy to be reactive and focus on team performance only when there's visible dysfunction or a crisis. But high-performing executive teams don't wait for a breakdown—they build their capability ahead of time. A high-performing executive team doesn't just manage the business—it multiplies its value. That doesn't happen by chance. It happens through intentional work, shared goals, and continuous practice. If your team isn't creating the value you know it could, it's not a failure of talent. It's a signal to invest in how you work together.
Yahoo
9 hours ago
- Yahoo
Halozyme Therapeutics Added to Russell 1000® Index
SAN DIEGO, June 30, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that it has been added to the U.S. large-cap Russell 1000® Index, effective after market close on June 27th, as part of the 2025 FTSE Russell indexes annual reconstitution. The Russell 1000® Index includes approximately 1,000 of the largest U.S. securities based on market capitalization and is widely used by investors as a benchmark for the performance of large-cap stocks. "Joining the Russell 1000 Index is an important milestone that reflects our leadership in rapid large-volume subcutaneous drug delivery and our track record of durable top-and-bottom line growth," said Dr. Helen Torley, President and CEO of Halozyme. "The inclusion will help to expand our visibility among the investment community as we continue to execute our strategy and deliver sustainable growth and profitability well into the future." The Russell 1000® is managed by FTSE Russell, a global leader in index and analytics. Membership in the Russell 1000® Index, which remains in place for one year, is based on membership in the broad-market Russell 3000® Index. About Halozyme Halozyme is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. As the innovators of ENHANZE® drug delivery technology with the proprietary enzyme rHuPH20, Halozyme's commercially-validated solution is used to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. Having touched one million patient lives in post-marketing use in ten commercialized products in at least one major region and across more than 100 global markets, Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical and Acumen Pharmaceuticals. Halozyme also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies that are designed to provide commercial or functional advantages such as improved convenience, reliability and tolerability, and enhanced patient comfort and adherence. The Company has two commercial proprietary products, Hylenex® and XYOSTED®, partnered commercial products and ongoing product development programs with Teva Pharmaceuticals and McDermott Laboratories Limited, an affiliate of Viatris Inc. Halozyme is headquartered in San Diego, CA and has offices in Ewing, NJ and Minnetonka, MN. Minnetonka is also the site of its operations facility. For more information visit and connect with us on LinkedIn and Twitter. Safe Harbor Statement In addition to historical information, the statements set forth above include forward-looking statements including, without limitation, statements concerning the future execution of Halozyme's strategy and delivery of future sustainable growth and profitability, the durability of Halozyme's top and bottom line growth, the possible activity, benefits and attributes of ENHANZE®, the possible method of action of ENHANZE®, its potential application to aid in the dispersion and absorption of other injected therapeutic drugs, and statements concerning certain other potential benefits of ENHANZE® including facilitating more rapid delivery of injectable medications through subcutaneous delivery and potentially lowering the treatment burden for patients. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements are typically, but not always, identified through use of the words "expect," "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of several factors, including unexpected results in the execution of Halozyme's strategy and unexpected future financial results and top and bottom line growth,. These and other factors that may result in differences are discussed in greater detail in Halozyme's most recent Annual and Quarterly Reports filed with the Securities and Exchange Commission. Except as required by law, Halozyme undertakes no duty to update forward-looking statements to reflect events after the date of this release. Contacts: Tram BuiVP, Investor Relations and Corporate Communications609-333-7668tbui@ Sydney View original content to download multimedia: SOURCE Halozyme Therapeutics, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
